カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のニチノールベース心臓病向け介入装置市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Nitinol-based Interventional Cardiology Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8212）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8212
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のニチノールベース心臓病向け介入装置市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ニチノールベース心臓病向け介入装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニチノールベース心臓病向け介入装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニチノールベース心臓病向け介入装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ステント、ガイドワイヤー、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界のニチノールベース心臓病向け介入装置市場の主要な市場プレーヤーは以下のとおりです。
・Abbott、Edwards Lifesciences、Medtronic、Boston Scientific、TERUMO、BD、Stryker、Cook Medical、Cordis、B. Braun、Biotronik、MicroPort、JOTEC、Acandis、ELLA-CS

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニチノールベース心臓病向け介入装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニチノールベース心臓病向け介入装置メーカーの企業概要、2019年～2022年までのニチノールベース心臓病向け介入装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニチノールベース心臓病向け介入装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニチノールベース心臓病向け介入装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニチノールベース心臓病向け介入装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニチノールベース心臓病向け介入装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニチノールベース心臓病向け介入装置の産業チェーンを掲載しています。
・第13、14、15章では、ニチノールベース心臓病向け介入装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Edwards Lifesciences、Medtronic、Boston Scientific、TERUMO、BD、Stryker、Cook Medical、Cordis、B. Braun、Biotronik、MicroPort、JOTEC、Acandis、ELLA-CS
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ステント、ガイドワイヤー、その他
・用途別分析2017年-2028年：病院、クリニック、その他
・ニチノールベース心臓病向け介入装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ニチノールベース心臓病向け介入装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ニチノールベース心臓病向け介入装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ニチノールベース心臓病向け介入装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ニチノールベース心臓病向け介入装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nitinol-based Interventional Cardiology Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nitinol-based Interventional Cardiology Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Nitinol-based Interventional Cardiology Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nitinol-based Interventional Cardiology Devices include Abbott, Edwards Lifesciences, Medtronic, Boston Scientific, and TERUMO, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nitinol-based Interventional Cardiology Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Stents
Guidewires
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Nitinol-based Interventional Cardiology Devices market are listed below:
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nitinol-based Interventional Cardiology Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nitinol-based Interventional Cardiology Devices, with price, sales, revenue and global market share of Nitinol-based Interventional Cardiology Devices from 2019 to 2022.
Chapter 3, the Nitinol-based Interventional Cardiology Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nitinol-based Interventional Cardiology Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nitinol-based Interventional Cardiology Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nitinol-based Interventional Cardiology Devices.
Chapter 13, 14, and 15, to describe Nitinol-based Interventional Cardiology Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Nitinol-based Interventional Cardiology Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nitinol-based Interventional Cardiology Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Stents
1.2.3 Guidewires
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nitinol-based Interventional Cardiology Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nitinol-based Interventional Cardiology Devices Market Size & Forecast
1.4.1 Global Nitinol-based Interventional Cardiology Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nitinol-based Interventional Cardiology Devices Sales in Volume (2017-2028)
1.4.3 Global Nitinol-based Interventional Cardiology Devices Price (2017-2028)
1.5 Global Nitinol-based Interventional Cardiology Devices Production Capacity Analysis
1.5.1 Global Nitinol-based Interventional Cardiology Devices Total Production Capacity (2017-2028)
1.5.2 Global Nitinol-based Interventional Cardiology Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nitinol-based Interventional Cardiology Devices Market Drivers
1.6.2 Nitinol-based Interventional Cardiology Devices Market Restraints
1.6.3 Nitinol-based Interventional Cardiology Devices Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Nitinol-based Interventional Cardiology Devices Product and Services
2.1.4 Abbott Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Edwards Lifesciences
2.2.1 Edwards Lifesciences Details
2.2.2 Edwards Lifesciences Major Business
2.2.3 Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Product and Services
2.2.4 Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Nitinol-based Interventional Cardiology Devices Product and Services
2.3.4 Medtronic Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Boston Scientific
2.4.1 Boston Scientific Details
2.4.2 Boston Scientific Major Business
2.4.3 Boston Scientific Nitinol-based Interventional Cardiology Devices Product and Services
2.4.4 Boston Scientific Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 TERUMO
2.5.1 TERUMO Details
2.5.2 TERUMO Major Business
2.5.3 TERUMO Nitinol-based Interventional Cardiology Devices Product and Services
2.5.4 TERUMO Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business
2.6.3 BD Nitinol-based Interventional Cardiology Devices Product and Services
2.6.4 BD Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Stryker
2.7.1 Stryker Details
2.7.2 Stryker Major Business
2.7.3 Stryker Nitinol-based Interventional Cardiology Devices Product and Services
2.7.4 Stryker Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cook Medical
2.8.1 Cook Medical Details
2.8.2 Cook Medical Major Business
2.8.3 Cook Medical Nitinol-based Interventional Cardiology Devices Product and Services
2.8.4 Cook Medical Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cordis
2.9.1 Cordis Details
2.9.2 Cordis Major Business
2.9.3 Cordis Nitinol-based Interventional Cardiology Devices Product and Services
2.9.4 Cordis Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 B. Braun
2.10.1 B. Braun Details
2.10.2 B. Braun Major Business
2.10.3 B. Braun Nitinol-based Interventional Cardiology Devices Product and Services
2.10.4 B. Braun Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Biotronik
2.11.1 Biotronik Details
2.11.2 Biotronik Major Business
2.11.3 Biotronik Nitinol-based Interventional Cardiology Devices Product and Services
2.11.4 Biotronik Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 MicroPort
2.12.1 MicroPort Details
2.12.2 MicroPort Major Business
2.12.3 MicroPort Nitinol-based Interventional Cardiology Devices Product and Services
2.12.4 MicroPort Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 JOTEC
2.13.1 JOTEC Details
2.13.2 JOTEC Major Business
2.13.3 JOTEC Nitinol-based Interventional Cardiology Devices Product and Services
2.13.4 JOTEC Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Acandis
2.14.1 Acandis Details
2.14.2 Acandis Major Business
2.14.3 Acandis Nitinol-based Interventional Cardiology Devices Product and Services
2.14.4 Acandis Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 ELLA-CS
2.15.1 ELLA-CS Details
2.15.2 ELLA-CS Major Business
2.15.3 ELLA-CS Nitinol-based Interventional Cardiology Devices Product and Services
2.15.4 ELLA-CS Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nitinol-based Interventional Cardiology Devices Breakdown Data by Manufacturer
3.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nitinol-based Interventional Cardiology Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Nitinol-based Interventional Cardiology Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Nitinol-based Interventional Cardiology Devices Manufacturer Market Share in 2021
3.5 Global Nitinol-based Interventional Cardiology Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nitinol-based Interventional Cardiology Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nitinol-based Interventional Cardiology Devices Market Size by Region
4.1.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2028)
4.2 North America Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.3 Europe Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.4 Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.5 South America Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.6 Middle East and Africa Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Type (2017-2028)
5.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Type (2017-2028)
5.3 Global Nitinol-based Interventional Cardiology Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Application (2017-2028)
6.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Application (2017-2028)
6.3 Global Nitinol-based Interventional Cardiology Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
7.2 North America Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
7.3 North America Nitinol-based Interventional Cardiology Devices Market Size by Country
7.3.1 North America Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
8.2 Europe Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
8.3 Europe Nitinol-based Interventional Cardiology Devices Market Size by Country
8.3.1 Europe Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Nitinol-based Interventional Cardiology Devices Market Size by Region
9.3.1 Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
10.2 South America Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
10.3 South America Nitinol-based Interventional Cardiology Devices Market Size by Country
10.3.1 South America Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Nitinol-based Interventional Cardiology Devices Market Size by Country
11.3.1 Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nitinol-based Interventional Cardiology Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nitinol-based Interventional Cardiology Devices
12.3 Nitinol-based Interventional Cardiology Devices Production Process
12.4 Nitinol-based Interventional Cardiology Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nitinol-based Interventional Cardiology Devices Typical Distributors
13.3 Nitinol-based Interventional Cardiology Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のニチノールベース介入装置市場2022年：市場規模予測（～2028年）
  • 介入型心血管・末梢血管用装置のグローバル市場展望 2023年-2029年：血管形成用バルーン、カテーテル、血管形成用ステント、その他
  • 世界の介入耳鼻咽喉科デバイス市場2022年：市場規模予測（～2028年）
  • 心臓手術＆インターベンショナルカーディオロジーのグローバル市場展望 2023年-2029年：心臓手術用機器、心臓インターベンション機器
  • 世界の統合心臓病デバイス市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8212 )"世界のニチノールベース心臓病向け介入装置市場2022年：市場規模予測（～2028年）" (英文：Global Nitinol-based Interventional Cardiology Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。